AMDL Rejoins Listed Stocks on the OTC
AMDL Inc., a Tustin developer of diagnostic tests for cancer and other diseases, said Monday its shares have been relisted on the over-the-counter market under the symbol AMDD. The shares were delisted Aug. 3 until the company filed required documents with the Securities and Exchange Commission.
The stock closed Monday at $5, up 38 cents a share, in trading of 400 shares. The shares closed at $2.50 on Aug. 3.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
